Ho W Y, Cooke M P, Goodnow C C, Davis M M
Department of Microbiology and Immunology, Stanford University School of Medicine, California 94305.
J Exp Med. 1994 May 1;179(5):1539-49. doi: 10.1084/jem.179.5.1539.
Successful antibody production in vivo depends on a number of cellular events, one of the most important of these being cognate B cell-T cell interaction. To examine this phenomenon in vitro, homogeneous populations of hen egg lysozyme (HEL)-specific small resting B cells and naive CD4+ HEL-specific T cells (derived from immunoglobulin [Ig] and T cell receptor transgenic mice, respectively) were cultured together. On addition of intact HEL protein. HEL-specific B cells increase their expression of activation molecules, including a B7-related protein and CD44, and enlarge into blast cells. Within the same cultures, HEL-specific CD4+ T cells also increase expression of the activation markers CD69 and CD44, enlarge, secrete lymphokines, and proliferate. This response is radiation sensitive, supporting the conclusion that HEL-specific B cells present antigen to and activate the naive T cells. By contrast, when a synthetic peptide fragment of HEL is used to bypass B cell antigen-receptor engagement, the naive T cells enlarge and display activation antigens, but fail to produce lymphokines, proliferate, or promote B cell blastogenesis. Presentation of HEL by tolerant B cells, which are no longer able to signal effectively through their antigen receptors, results in an identical pattern of incomplete T cell activation. Addition of a stimulating anti-CD28 antibody and blocking of CD28 signals with CTLA4/Ig fusion protein both show that complete activation of naive CD4+ T cells depends on the initial induction of B7 and related costimulatory molecules after HEL binding to nontolerant HEL-specific B cells. Thus, in the absence of adequate constimulation from the B cell, naive CD4+ T cells undergo a form of "partial activation" in which they upregulate surface expression of certain T cell activation antigens, but fail to efficiently produce lymphokine and proliferate. This may explain the different conclusions that have been reached regarding the consequences of B cell antigen presentation to T cells, in that the ability of B cells to activate naive CD4+ T cells depends both on their specificity and their activation state.
体内成功产生抗体取决于许多细胞事件,其中最重要的事件之一是同源B细胞与T细胞的相互作用。为了在体外研究这一现象,将鸡卵溶菌酶(HEL)特异性的静止小B细胞和幼稚CD4⁺ HEL特异性T细胞(分别来自免疫球蛋白[Ig]和T细胞受体转基因小鼠)的同质群体一起培养。加入完整的HEL蛋白后,HEL特异性B细胞增加其激活分子的表达,包括一种B7相关蛋白和CD44,并发育成母细胞。在相同培养物中,HEL特异性CD4⁺ T细胞也增加激活标志物CD69和CD44的表达,体积增大,分泌淋巴因子并增殖。这种反应对辐射敏感,支持了HEL特异性B细胞将抗原呈递给幼稚T细胞并激活它们这一结论。相比之下,当使用HEL的合成肽片段绕过B细胞抗原受体结合时,幼稚T细胞体积增大并显示激活抗原,但不能产生淋巴因子、增殖或促进B细胞母细胞形成。耐受性B细胞不再能够通过其抗原受体有效发出信号,由其呈递HEL会导致相同模式的不完全T细胞激活。加入刺激性抗CD28抗体并用CTLA4/Ig融合蛋白阻断CD28信号均表明,幼稚CD4⁺ T细胞的完全激活取决于HEL与非耐受性HEL特异性B细胞结合后B7和相关共刺激分子的初始诱导。因此,在缺乏来自B细胞的充分共刺激的情况下,幼稚CD4⁺ T细胞经历一种“部分激活”形式,其中它们上调某些T细胞激活抗原的表面表达,但不能有效地产生淋巴因子和增殖。这可能解释了关于B细胞向T细胞呈递抗原的后果所达成的不同结论,因为B细胞激活幼稚CD4⁺ T细胞的能力既取决于它们的特异性,也取决于它们的激活状态。